Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
2.710
-0.080 (-2.87%)
Nov 21, 2024, 2:24 PM EST - Market open
Inozyme Pharma Employees
Inozyme Pharma had 59 employees as of December 31, 2023. The number of employees increased by 3 or 5.36% compared to the previous year.
Employees
59
Change (1Y)
3
Growth (1Y)
5.36%
Revenue / Employee
n/a
Profits / Employee
-$1,635,492
Market Cap
174.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 59 | 3 | 5.36% |
| Dec 31, 2022 | 56 | 6 | 12.00% |
| Dec 31, 2021 | 50 | 12 | 31.58% |
| Dec 31, 2020 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 274 |
| Cellectis | 221 |
| Biodesix | 217 |
| Nektar Therapeutics | 137 |
| BrainsWay | 134 |
| Senseonics Holdings | 132 |
| Heron Therapeutics | 126 |
| Nanobiotix | 102 |
INZY News
- 10 days ago - Inozyme Pharma to Present at Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 4 weeks ago - Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701 - GlobeNewsWire
- 5 weeks ago - Inozyme Pharma Announces Presentation of Interim Data from Phase 1 SEAPORT 1 Trial at the Upcoming American Society of Nephrology (ASN) Kidney Week 2024 - GlobeNewsWire
- 6 weeks ago - Inozyme Pharma Announces Appointment of Biopharmaceutical Commercial Leader Erik Harris to its Board of Directors - GlobeNewsWire
- 2 months ago - Why Analyst Says Rare Disease-Focused Inozyme Pharma Stock 'Could Be Worth A Look' - Benzinga
- 3 months ago - Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference - GlobeNewsWire
- 4 months ago - Inozyme: Q4 Of 2024 Phase 1 INZ-701 Data Could Lead To Indication Expansion - Seeking Alpha